• Blunted antiviral responses in the nasopharynx may underlie severe COVID-19

    1 month ago - By News Medical

    The body's first encounter with SARS-CoV-2, the virus behind COVID-19, happens in the nose and throat, or nasopharynx. A new study in the journal Cell suggests that the first responses in this battleground help determine who will develop severe disease and who will get through with mild or no illness.
    Read more ...

     

  • Advantages and challenges of intranasal vaccines to fight against COVID-19 infections

    1 month ago - By News Medical

    There are many reasons that an intranasal vaccine against the SARS-CoV-2 virus would be helpful in the fight against COVID-19 infections, University of Alabama at Birmingham immunologists Fran Lund, Ph.D., and Troy Randall, Ph.D., write in a viewpoint article in the journal Science.
    Read more ...

     

  • Patents Prove SARS-CoV-2 Is a Manufactured Virus

    1 month ago - By Mercola

    In a January 2021 lecture, Jonathan Latham, Ph.D., introduced the term "the pandemic virus industrial complex," to describe the academic, military and commercial complexes that are driving the pandemic agenda and obscuring facts that indicate SARS-CoV-2 is a manmade virus.
    In the video above, David E. Martin, Ph.D., introduces shocking evidence that SARS-CoV-2 is indeed a manmade bioweapon, and has been in the works for decades. Much of this research was funded by none other than the National Institutes of Allergy and Infectious Diseases under the direction of Dr. Anthony Fauci.
    Pandemic...
    Read more ...